Ascent Wealth Partners LLC Sells 226 Shares of Danaher Co. (NYSE:DHR)

Ascent Wealth Partners LLC lowered its holdings in shares of Danaher Co. (NYSE:DHRFree Report) by 18.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,024 shares of the conglomerate’s stock after selling 226 shares during the quarter. Ascent Wealth Partners LLC’s holdings in Danaher were worth $237,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Essex Savings Bank grew its position in shares of Danaher by 10.8% during the 4th quarter. Essex Savings Bank now owns 4,541 shares of the conglomerate’s stock valued at $1,051,000 after acquiring an additional 444 shares during the period. Osborne Partners Capital Management LLC increased its position in Danaher by 2.6% in the fourth quarter. Osborne Partners Capital Management LLC now owns 89,554 shares of the conglomerate’s stock worth $20,717,000 after buying an additional 2,307 shares in the last quarter. Bridge Creek Capital Management LLC lifted its position in shares of Danaher by 7.3% during the 4th quarter. Bridge Creek Capital Management LLC now owns 10,248 shares of the conglomerate’s stock valued at $2,371,000 after buying an additional 695 shares in the last quarter. Norris Perne & French LLP MI grew its stake in shares of Danaher by 1.8% during the 4th quarter. Norris Perne & French LLP MI now owns 77,146 shares of the conglomerate’s stock valued at $17,847,000 after acquiring an additional 1,351 shares during the period. Finally, SevenBridge Financial Group LLC increased its holdings in Danaher by 5.1% in the 4th quarter. SevenBridge Financial Group LLC now owns 1,558 shares of the conglomerate’s stock worth $360,000 after acquiring an additional 75 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.8 %

Shares of NYSE:DHR traded down $1.86 during trading on Tuesday, hitting $245.93. The company had a trading volume of 718,230 shares, compared to its average volume of 2,716,478. The stock has a market cap of $182.12 billion, a price-to-earnings ratio of 38.78, a price-to-earnings-growth ratio of 3.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.68 and a quick ratio of 1.37. The company has a fifty day simple moving average of $248.33 and a two-hundred day simple moving average of $230.34. Danaher Co. has a one year low of $182.09 and a one year high of $259.00.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $1.91 by $0.18. The firm had revenue of $6.41 billion for the quarter, compared to analysts’ expectations of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The company’s quarterly revenue was down 10.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.87 earnings per share. As a group, equities analysts forecast that Danaher Co. will post 7.62 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be issued a $0.27 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Wednesday, March 27th. Danaher’s payout ratio is presently 16.90%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on DHR. Raymond James lifted their price target on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. The Goldman Sachs Group downgraded Danaher from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $215.00 to $205.00 in a research report on Thursday, December 7th. Citigroup boosted their price target on Danaher from $255.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. HSBC started coverage on shares of Danaher in a report on Monday, December 18th. They set a “hold” rating for the company. Finally, Royal Bank of Canada boosted their target price on shares of Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Seven analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $266.00.

View Our Latest Stock Report on DHR

Insider Buying and Selling

In other news, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the sale, the senior vice president now owns 38,102 shares in the company, valued at approximately $9,601,704. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now directly owns 38,102 shares in the company, valued at approximately $9,601,704. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the sale, the senior vice president now owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The disclosure for this sale can be found here. Insiders sold a total of 32,957 shares of company stock valued at $8,265,802 over the last three months. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.